Choice of Treatment for Stage IA Non-small Cell Lung Cancer Patients Ineligible for Surgery: Ablation or Stereotactic Body Radiotherapy?

scientific article published on 14 January 2020

Choice of Treatment for Stage IA Non-small Cell Lung Cancer Patients Ineligible for Surgery: Ablation or Stereotactic Body Radiotherapy? is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.7150/JCA.39465
P932PMC publication ID6995377
P698PubMed publication ID32047569

P2093author name stringAimei Peng
Long Liang
Fenyong Sun
Guifeng Sun
Mengmei Zhang
Guoshu Li
Shuanshuan Xie
P2860cites workSurvival Rates after Thermal Ablation versus Stereotactic Radiation Therapy for Stage 1 Non-Small Cell Lung Cancer: A National Cancer Database StudyQ91504354
Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of originQ26826437
Lung cancer ablation: what is the evidence?Q26864744
Image-guided thermal ablation of lung malignanciesQ33994324
Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysisQ33997877
Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patientsQ34003208
Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancerQ34575077
Radiation effects on the lung: clinical features, pathology, and imaging findingsQ35533741
Percutaneous CT-guided microwave ablation as maintenance after first-line treatment for patients with advanced NSCLCQ36267763
Pneumothorax, pleural effusion, and chest tube placement after radiofrequency ablation of lung tumors: incidence and risk factorsQ36565517
Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd edition).Q36943220
Microwave ablation of lung malignancies: effectiveness, CT findings, and safety in 50 patientsQ37121411
A systematic review of outcomes following stereotactic ablative radiotherapy in the treatment of early-stage primary lung cancerQ38790915
Multi-Institutional Experience of Stereotactic Ablative Radiation Therapy for Stage I Small Cell Lung CancerQ39068176
Unresectable pulmonary malignancies: CT-guided percutaneous radiofrequency ablation--preliminary results.Q40544841
Radiation change in normal organs: an overview of body imagingQ41277919
Cancer statistics, 2018.Q47191906
Air embolism during needle placement for CT-guided radiofrequency ablation of an unresectable metastatic lung lesion.Q50850298
Stereotactic ablative radiation therapy for centrally located early stage or isolated parenchymal recurrences of non-small cell lung cancer: how to fly in a "no fly zone".Q51100099
Thoracic masses treated with percutaneous cryotherapy: initial experience with more than 200 procedures.Q53589874
Stereotactic Body Radiation Therapy for Operable Early-Stage Lung Cancer: Findings From the NRG Oncology RTOG 0618 TrialQ56523398
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†Q59587188
Guidelines on the radical management of patients with lung cancerQ61583905
Nonfatal systemic air embolism during percutaneous radiofrequency ablation of a pulmonary metastasisQ80159369
CT-guided conformal cryoablation for peripheral NSCLC: initial experienceQ84210528
Complications after 1000 lung radiofrequency ablation sessions in 420 patients: a single center's experiencesQ84975053
Stereotactic body radiation therapy for stage I non-small cell lung carcinomas: Moderate hypofractionation optimizes outcomeQ90345376
P433issue6
P921main subjectnon-small-cell lung carcinomaQ3658562
P304page(s)1634-1640
P577publication date2020-01-14
P1433published inJournal of CancerQ6294901
P1476titleChoice of Treatment for Stage IA Non-small Cell Lung Cancer Patients Ineligible for Surgery: Ablation or Stereotactic Body Radiotherapy?
P478volume11

Search more.